CHRONIC LI+ ATTENUATES AGONIST-MEDIATED AND PHORBOL ESTER-MEDIATED NA+/H+ ANTIPORTER ACTIVITY IN HL-60 CELLS

被引:30
作者
BITRAN, JA
POTTER, WZ
MANJI, HK
GUSOVSKY, F
机构
[1] NIDDK,BIOORGAN CHEM LAB,BETHESDA,MD 20892
[2] NIMH,CLIN SCI LAB,CLIN PHARMACOL SECT,BETHESDA,MD 20892
来源
EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION | 1990年 / 188卷 / 4-5期
关键词
LI+; NA+/H+ EXCHANGE; HL-60; CELLS; PHORBOL ESTER; PHOSPHOINOSITIDES;
D O I
10.1016/0922-4106(90)90002-F
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The effects of Li+ on signal transduction in dibutyryl cAMP-differentiated HL-60 cells were studied. Upon differentiation, these human promyelocytic leukemia cells express a chemotactic formyl peptide receptor, which is coupled through a guanine nucleotide-binding protein to phospholipase C. Stimulation with fMet-Leu-Phe results in changes in intracellular pH which are thought to be mediated by protein kinase C regulation of Na+/H+ antiporter function. Acute LiCl treatment (10 mM) was without any effect on Na+/H+ activity. However, pretreatment of HL-60 cells with 1 or 10 mM LiCl for at least 5 days resulted in a marked attenuation of fMet-Leu-Phe effects on Na+/H+ activity. In undifferentiated HL-60 cells, which lack fMet-Leu-Phe receptors, intracellular acidification induced by the proton ionophore nigericin generates an alkalinization response. Chronic (but not acute) Li+ treatment also resulted in an inhibition of the nigericin-mediated response. Furthermore, stimulation of the Na+/H+ antiporter by the phorbol ester, phorbol-12-myristate-13-acetate, was also markedly attenuated by chronic LiCl treatment, suggesting an impairment of protein kinase C activity. In contrast, fMet-Leu-Phe-induced increases in intracellular Ca2+ and phospho-inositide breakdown were unchanged in cells treated with Li+ for 5 days. These results indicate that chronic but not acute Li+ treatment alters intracellular pH regulation possibly at a site distal to the fMet-Leu-Phe receptor.
引用
收藏
页码:193 / 202
页数:10
相关论文
共 40 条
[1]   INCREASED BRAIN MYOINOSITOL 1-PHOSPHATE IN LITHIUM-TREATED RATS [J].
ALLISON, JH ;
BLISNER, ME ;
HOLLAND, WH ;
HIPPS, PP ;
SHERMAN, WR .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1976, 71 (02) :664-670
[2]  
BALLESTER R, 1985, J BIOL CHEM, V260, P5194
[3]   BETA-ADRENERGIC-RECEPTOR KINASE - IDENTIFICATION OF A NOVEL PROTEIN-KINASE THAT PHOSPHORYLATES THE AGONIST-OCCUPIED FORM OF THE RECEPTOR [J].
BENOVIC, JL ;
STRASSER, RH ;
CARON, MG ;
LEFKOWITZ, RJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (09) :2797-2801
[4]  
BERRIDGE MJ, 1987, ANNU REV BIOCHEM, V56, P159, DOI 10.1146/annurev.bi.56.070187.001111
[5]  
BESTERMAN JM, 1985, J BIOL CHEM, V260, P1155
[6]  
BLACKSHEAR PJ, 1985, J BIOL CHEM, V260, P3304
[7]  
BUNNEY WE, 1987, PSYCHOPHARMACOLOGY 3, P553
[8]   CYCLIC NUCLEOTIDE-INDUCED MATURATION OF HUMAN PROMYELOCYTIC LEUKEMIA-CELLS [J].
CHAPLINSKI, TJ ;
NIEDEL, JE .
JOURNAL OF CLINICAL INVESTIGATION, 1982, 70 (05) :953-964
[9]  
CHUANG DM, 1989, ANNU REV PHARMACOL, V29, P71
[10]  
COCKCROFT S, 1988, PHILOS T R SOC LOND, V26, P320